BusinessBioCorRx Gains Additional Media Coverage from Fox Medical Correspondent Who Discusses the Advantages of the Naltrexone ImplantBy Nasdaq OMXApr 30, 2018, 11:01 AM UTC
BusinessBioCorRx CEO Brady Granier and Actor Jeremy Miller Appear on Varney & Co. on Fox Business to Discuss the Company's Sustained Release Naltrexone Implant for Alcohol Use DisorderBy Nasdaq OMXApr 26, 2018, 12:47 PM UTC
BusinessBioCorRx to Participate in the First Annual Orange County Recovery Collaborative Resource FairBy Nasdaq OMXApr 13, 2018, 11:19 AM UTC
BusinessBioCorRx to Exhibit at ASAM 49th Annual Conference in San Diego, CaliforniaBy Nasdaq OMXApr 10, 2018, 11:30 AM UTC
BusinessBioCorRx CEO Brady Granier and Legendary Soul Man Sam Moore Appear on Fox Business Network to Discuss the Company's Naltrexone Implant, Which Helps Combat Opioid AddictionBy Nasdaq OMXApr 9, 2018, 4:25 PM UTC
BusinessBioCorRx Provides Business Update for the Full Year Ended 2017By Nasdaq OMXApr 6, 2018, 11:30 AM UTC
BusinessBioCorRx Comments on President Donald J. Trump’s Initiative to Stop Opioid AbuseBy Nasdaq OMXMar 20, 2018, 2:40 PM UTC
BusinessBioCorRx Provides Update on New Weight Management ProgramBy Nasdaq OMXMar 15, 2018, 12:08 PM UTC
